Enzon Pharmaceuticals, Inc. (ENZN)
0.06
0.00 (0.00%)
USD |
OTCM |
Mar 06, 16:00
Enzon Pharmaceuticals SG&A Expense (TTM) : 1.545M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Agenus, Inc. | 63.03M |
| Curis, Inc. | 14.52M |
| Plus Therapeutics, Inc. | 11.09M |
| Windtree Therapeutics, Inc. | 7.706M |
| Halozyme Therapeutics, Inc. | 207.09M |